Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18

News > Business News

Audio By Carbonatix

7:15 AM on Tuesday, January 20

The Associated Press

VAUGHAN, Ontario--(BUSINESS WIRE)--Jan 20, 2026--

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2025 financial results on Wednesday, Feb. 18, 2026. The company will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call.

Conference Call Details

Date:			Wednesday, Feb. 18, 2026

Time:			8:00 a.m. ET

Webcast:			https://www.webcaster5.com/Webcast/Page/2883/53392

Participant Event Dial-in:			+1 (888) 506-0062 (North America) +1 (973) 528-0011 (International)

Participant Access Code:			923960

Replay Dial-in:			+1 (877) 481-4010 (North America) +1 (919) 882-2331 (International)

Replay Passcode:			53392 (replay available until March 4, 2026)

About Bausch + Lomb
Our mission is simple – we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260120475176/en/

CONTACT: Media Contact:

Chris Clark

[email protected]

(848) 360-1100

Investor Contact:

George Gadkowski

[email protected]

(877) 354-3705 (toll free)

KEYWORD: NORTH AMERICA CANADA

INDUSTRY KEYWORD: GENERAL HEALTH PHARMACEUTICAL OPTICAL HEALTH

SOURCE: Bausch + Lomb Corporation